Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MN2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,320
Award facts
- Contract value 100% obligated
- $33,319.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,319.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 22, 2026, for the supply of RINVOQ ER 45 mg tablets (28-count units). The contract, which is not set-aside and represents a competitive award, is scheduled for completion by January 23, 2026, and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under the company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial $999.99 million Indefinite Delivery Contract with DLA Troop Support Medical through December 2031.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, and this delivery order exemplifies the company's role in supplying specialized medications to support Department of Defense medical operations. The underlying IDC vehicle with DLA encompasses a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and generic drugs needed across multiple therapeutic domains for military treatment facilities and other federal healthcare institutions. AmerisourceBergen's consistent competitive success in federal pharmaceutical procurement demonstrates its capability to meet government medical supply requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26F9MN2?
SPE2DR26F9MN2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9MN2 worth?
The government has obligated $33,320 on SPE2DR26F9MN2.
Is contract SPE2DR26F9MN2 an order under another contract?
Yes. SPE2DR26F9MN2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MN2 competed?
The extent of competition for SPE2DR26F9MN2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award